| Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and … VG Athyros, K Tziomalos, TD Gossios, T Griva, P Anagnostis, K Kargiotis, ... The Lancet 376 (9756), 1916-1922, 2010 | 873 | 2010 |
| The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis P Anagnostis, VG Athyros, K Tziomalos, A Karagiannis, DP Mikhailidis The Journal of Clinical Endocrinology & Metabolism 94 (8), 2692-2701, 2009 | 807 | 2009 |
| Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study VG Athyros, DP Mikhailidis, TP Didangelos, OI Giouleme, ... Current medical research and opinion 22 (5), 873-883, 2006 | 334 | 2006 |
| Diabetic nephropathy: new risk factors and improvements in diagnosis K Tziomalos, VG Athyros The review of diabetic studies: RDS 12 (1-2), 110, 2015 | 288 | 2015 |
| Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a … VG Athyros, DP Mikhailidis, EN Liberopoulos, AI Kakafika, A Karagiannis, ... Nephrology Dialysis Transplantation 22 (1), 118-127, 2007 | 286 | 2007 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 283 | 2017 |
| Serum uric acid as an independent predictor of early death after acute stroke A Karagiannis, DP Mikhailidis, K Tziomalos, M Sileli, S Savvatianos, ... Circulation Journal 71 (7), 1120-1127, 2007 | 231 | 2007 |
| Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management K Tziomalos, VG Athyros, A Karagiannis, DP Mikhailidis Nutrition, Metabolism and Cardiovascular Diseases 20 (2), 140-146, 2010 | 230 | 2010 |
| Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? P Anagnostis, A Karagiannis, AI Kakafika, K Tziomalos, VG Athyros, ... Osteoporosis International 20, 197-207, 2009 | 220 | 2009 |
| Pleiotropic effects of statins-clinical evidence VG Athyros, AI Kakafika, K Tziomalos, A Karagiannis, DP Mikhailidis Current pharmaceutical design 15 (5), 479-489, 2009 | 214 | 2009 |
| Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease … VG Athyros, EN Liberopoulos, DP Mikhailidis, AA Papageorgiou, ... Angiology 58 (6), 689-697, 2007 | 210 | 2007 |
| Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update VG Athyros, K Tziomalos, N Katsiki, M Doumas, A Karagiannis, ... World Journal of Gastroenterology: WJG 21 (22), 6820, 2015 | 191 | 2015 |
| Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study D Panidis, K Tziomalos, G Misichronis, E Papadakis, G Betsas, I Katsikis, ... Human reproduction 27 (2), 541-549, 2012 | 190 | 2012 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 176 | 2021 |
| Erectile dysfunction in patients with hyper-and hypothyroidism: how common and should we treat? GE Krassas, K Tziomalos, F Papadopoulou, N Pontikides, P Perros The Journal of Clinical Endocrinology & Metabolism 93 (5), 1815-1819, 2008 | 162 | 2008 |
| Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism A Karagiannis, K Tziomalos, A Papageorgiou, AI Kakafika, ... Expert opinion on pharmacotherapy 9 (4), 509-515, 2008 | 161 | 2008 |
| Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population VG Athyros, ES Ganotakis, K Tziomalos, AA Papageorgiou, P Anagnostis, ... Current medical research and opinion 26 (3), 713-719, 2010 | 151 | 2010 |
| Should adipokines be considered in the choice of the treatment of obesity-related health problems? VG Athyros, K Tziomalos, A Karagiannis, P Anagnostis, DP Mikhailidis Current drug targets 11 (1), 122-135, 2010 | 143 | 2010 |
| Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome D Macut, K Tziomalos, I Božić-Antić, J Bjekić-Macut, I Katsikis, ... Human reproduction 31 (6), 1347-1353, 2016 | 131 | 2016 |
| Dyslipidemia as a risk factor for ischemic stroke K Tziomalos, VG Athyros, A Karagiannis, DP Mikhailidis Current topics in medicinal chemistry 9 (14), 1291-1297, 2009 | 131 | 2009 |
